Skip to main content
Clinical Trials/NL-OMON52907
NL-OMON52907
Recruiting
Not Applicable

The effect of targeted nutrient supplementation on physical activity and health related quality of life in COPD - NUTRECOVER trial

Medisch Universitair Ziekenhuis Maastricht0 sites198 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic obstructive pulmonary disease
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
198
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • COPD patients NUTRECOVER trial:
  • \- COPD patients with moderate to very severe disease stage according to GOLD
  • criteria (i.e. GOLD stage II\-IV);
  • \- Medically stable in the opinion of the investigator.
  • Reference group microbiome study:
  • \- Lung function: FEV1/FVC \> 0\.7
  • \- Medically stable in the opinion of the investigator.

Exclusion Criteria

  • COPD patients NUTRECOVER trial:
  • Exclusion criteria indicated with an asterisk (\*) are also exclusion criteria
  • for the subjects in the reference group for the microbiome study.
  • \- Age \<18 years;\*
  • \- Allergy or intolerance to components of the study product;
  • \- Investigator\*s uncertainty about the willingness or ability of the patient to
  • comply with the protocol requirements (e.g. leg amputation) or patients
  • suffering from other acute or unstable chronic diseases that will compromise
  • the study outcome (e.g. active cancer requiring treatment);\*
  • \- Participation in any other study involving investigational or marketed

Outcomes

Primary Outcomes

Not specified

Similar Trials